BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30577460)

  • 21. Chemical Research on Antitumor Isoquinoline Marine Natural Products and Related Compounds.
    Saito N
    Chem Pharm Bull (Tokyo); 2021; 69(2):155-177. PubMed ID: 33518599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
    Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
    J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
    Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro evaluation of novel 1,2,3,4-tetrahydroisoquinoline derivatives as potent antiglioma agents.
    Patil R; Hosni-Ahmed A; Jones TS; Patil SA; Asres LB; Wang X; Yates RC; Geisert EE; Miller DD
    Anticancer Agents Med Chem; 2014 Mar; 14(3):473-82. PubMed ID: 24533653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-Activity Relationships and Potent Cytotoxic Activities of Terphenyllin Derivatives from a Small Compound Library.
    Haider W; Xu WF; Liu M; Wu YW; Tang YF; Wei MY; Wang CY; Lu L; Shao CL
    Chem Biodivers; 2020 Jul; 17(7):e2000207. PubMed ID: 32367656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4-tetrahydroisoquinoline derivatives.
    Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Arch Pharm Res; 2013 Sep; 36(9):1066-77. PubMed ID: 23604819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marine cytotoxic macrolides haterumalides and biselides, and related natural products.
    Kigoshi H; Hayakawa I
    Chem Rec; 2007; 7(4):254-64. PubMed ID: 17663448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4'-leucine-avarone.
    Pejin B; Iodice C; Tommonaro G; Bogdanovic G; Kojic V; De Rosa S
    Nat Prod Res; 2014; 28(5):347-50. PubMed ID: 24422776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Cytotoxicity, and Genotoxicity of 10-Aza-9-oxakalkitoxin, an
    Dhanju S; Upadhyaya K; Rice CA; Pegan SD; Media J; Valeriote FA; Crich D
    J Am Chem Soc; 2020 May; 142(20):9147-9151. PubMed ID: 32364709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
    Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
    Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the structure-activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A critical role played by the conjugated trienyl lactone moiety.
    Qian S; Shah AK; Head SA; Liu JO; Jin Z
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3411-3. PubMed ID: 27374243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.
    Buaban K; Innets B; Petsri K; Sinsook S; Chanvorachote P; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Chamni S
    Sci Rep; 2023 Dec; 13(1):21485. PubMed ID: 38057385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
    Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
    Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series.
    Tarby CM; Kaltenbach RF; Huynh T; Pudzianowski A; Shen H; Ortega-Nanos M; Sheriff S; Newitt JA; McDonnell PA; Burford N; Fairchild CR; Vaccaro W; Chen Z; Borzilleri RM; Naglich J; Lombardo LJ; Gottardis M; Trainor GL; Roussell DL
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2095-100. PubMed ID: 16458511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
    Li T; Fan P; Ye Y; Luo Q; Lou H
    Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and Synthesis of Tetrahydroisoquinoline Derivatives as Anti-Angiogenesis and Anti-Cancer Agents.
    Gangapuram M; Eyunni S; Zhang W; Redda KK
    Anticancer Agents Med Chem; 2021; 21(18):2505-2511. PubMed ID: 33438560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microarray-based transcriptional profiling of renieramycin M and jorunnamycin C, isolated from Thai marine organisms.
    Charupant K; Suwanborirux K; Daikuhara N; Yokoya M; Ushijima-Sugano R; Kawai T; Owa T; Saito N
    Mar Drugs; 2009 Oct; 7(4):483-94. PubMed ID: 20098592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].
    Wang YY; Zhang XJ; Yang YR; Sun HP; You QD
    Yao Xue Xue Bao; 2014 Mar; 49(3):293-302. PubMed ID: 24961098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment-Based Structural Optimization of a Natural Product Itampolin A as a p38α Inhibitor for Lung Cancer.
    Liang JW; Wang MY; Wang S; Li XY; Meng FH
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30642059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.